These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21542887)
1. Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'. Gonzalez-Gay MA; Gonzalez-Juanatey C; Miranda-Filloy JA; Martin J; Garcia-Unzueta MT; Llorca J Arthritis Res Ther; 2011 Apr; 13(2):404. PubMed ID: 21542887 [No Abstract] [Full Text] [Related]
2. Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months. Engvall IL; Tengstrand B; Brismar K; Hafström I Arthritis Res Ther; 2010; 12(5):R197. PubMed ID: 20964833 [TBL] [Abstract][Full Text] [Related]
3. Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis. Derdemezis CS; Filippatos TD; Voulgari PV; Tselepis AD; Drosos AA; Kiortsis DN Fundam Clin Pharmacol; 2009 Oct; 23(5):595-600. PubMed ID: 19563510 [TBL] [Abstract][Full Text] [Related]
4. A possible role of leptin-associated increase in soluble interleukin-2 receptor diminishing a clinical response to infliximab in rheumatoid arthritis: Comment on the article by Klaasen et al. Shin JI; Park SJ; Kim JH Arthritis Rheum; 2011 Sep; 63(9):2833-4; author reply 2834. PubMed ID: 21618200 [No Abstract] [Full Text] [Related]
5. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Serelis J; Kontogianni MD; Katsiougiannis S; Bletsa M; Tektonidou MG; Skopouli FN Clin Rheumatol; 2008 Jun; 27(6):795-7. PubMed ID: 18305977 [TBL] [Abstract][Full Text] [Related]
6. Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist. Kopec-Medrek M; Kotulska A; Widuchowska M; Adamczak M; Więcek A; Kucharz EJ Rheumatol Int; 2012 Nov; 32(11):3383-9. PubMed ID: 22048440 [TBL] [Abstract][Full Text] [Related]
7. In early rheumatoid arthritis the combination of methotrexate and infliximab over 2 years reduces the progression of radiological lesions more than methotrexate alone. Montecucco C Clin Exp Rheumatol; 2005; 23(3):289-291. PubMed ID: 15971414 [No Abstract] [Full Text] [Related]
9. Infliximab: a new treatment for rheumatoid arthritis. Emery P Hosp Med; 2001 Mar; 62(3):150-2. PubMed ID: 11291464 [TBL] [Abstract][Full Text] [Related]
10. Return of infliximab efficacy after total knee arthroplasty in a patient with rheumatoid arthritis. Toki H; Momohara S; Ikari K; Kawamura K; Tsukahara S; Mochizuki T; Sato E; Yamanaka H Clin Rheumatol; 2008 Apr; 27(4):549-50. PubMed ID: 18299787 [No Abstract] [Full Text] [Related]
11. Early rheumatoid arthritis treatments weighed. Mitka M JAMA; 2005 Dec; 294(24):3073-4. PubMed ID: 16380583 [No Abstract] [Full Text] [Related]
12. Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis. Cobo Ibáñez T; Yehia Tayel M; Balsa Criado A; Hernández Sanz A; Martín Mola E Rheumatology (Oxford); 2005 Nov; 44(11):1467-8. PubMed ID: 16174647 [No Abstract] [Full Text] [Related]
13. Improved response to infliximab after leukocytapheresis in a patent with rheumatoid arthritis. Azuma T; Ishimaru H; Hatta K; Kori Y Mod Rheumatol; 2007; 17(3):253-5. PubMed ID: 17564785 [TBL] [Abstract][Full Text] [Related]
14. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al. Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353 [No Abstract] [Full Text] [Related]
15. Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. Vis M; Wolbink GJ; Lodder MC; Kostense PJ; van de Stadt RJ; de Koning MH; Dijkmans BA; Lems WF Arthritis Rheum; 2003 Oct; 48(10):2996-7. PubMed ID: 14558111 [No Abstract] [Full Text] [Related]
16. Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients. Brocq O; Albert C; Roux C; Gerard D; Breuil V; Ziegler LE Joint Bone Spine; 2004 Nov; 71(6):601-3. PubMed ID: 15589452 [No Abstract] [Full Text] [Related]
17. Additional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis. Mori S Mod Rheumatol; 2012 Nov; 22(6):947-50. PubMed ID: 22350573 [No Abstract] [Full Text] [Related]
18. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks. Yokoe I; Nishio S; Sato H; Kobayashi H Mod Rheumatol; 2011 Dec; 21(6):710-4. PubMed ID: 21656090 [No Abstract] [Full Text] [Related]
19. [Disseminated tuberculosis in patient with rheumatoid arthritis after infliximab therapy]. Ramos González A; Corzo Delgado JE; Sánchez Bursón J Med Clin (Barc); 2002 Nov; 119(16):636-7. PubMed ID: 12433341 [No Abstract] [Full Text] [Related]
20. [New trends in therapy for arthritis rheumatoid]. Tanaka Y Nihon Naika Gakkai Zasshi; 2006 Mar; 95(3):505-9. PubMed ID: 16640082 [No Abstract] [Full Text] [Related] [Next] [New Search]